Johnson & Johnson to start late-stage coronavirus vaccine trial in September with up to 60,000 people – CNBC

Johnson & Johnson plans to begin what would be the largest, late-stage trial testing a potential coronavirus vaccine in September, the company confirmed Thursday.
The phase three trial would enr… [+698 chars]